Abstract
In aortic stenosis (AS), metabolic syndrome (MetS) and diabetes mellitus (DM) are associated with more left ventricular (LV) hypertrophy. We aimed to examine the impact of MetS/DM on LV mass in patients with severe AS referred to aortic valve replacement (AVR) and on the LV mass regression after AVR
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.